CYTOMEL

This brand name is authorized in United States. It is also authorized in Canada, Malta, Netherlands.

Active ingredients

The drug CYTOMEL contains one active pharmaceutical ingredient (API):

1	Liothyronine UNII GCA9VV7D2N - LIOTHYRONINE SODIUM
	Liothyronine sodium is a naturally occurring thyroid hormone. The biological action of liothyronine sodium is quantitatively similar to that of levothyroxine sodium.
	Read more about Liothyronine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CYTOMEL Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H03AA02	Liothyronine sodium	H Systemic hormonal preparations, excl. Sex hormones and insulins → H03 Thyroid therapy → H03A Thyroid preparations → H03AA Thyroid hormones
Discover more medicines within H03AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	01919458, 01919466
MT	Medicines Authority	AA565/57601, AA729/32601
NL	Z-Index G-Standaard, PRK	126926, 4634, 97551
US	FDA, National Drug Code	60793-115, 60793-116, 60793-117